Skip to main content

Healthcare Collaterals- Mobiles based Healthcare



Pharma Companies under Focus

How can Mobiles add value to the B2B order processing and Process Management?

Here you will have to go by the Healthcare Value chain. Mobility value add in Order processing i.e. B2B will be helpful only if:


It eases out product procurement and delivery

It helps stumbling blocks to improved value chain operations


For this one need to understand the strategies in three product areas i.e. pharmaceuticals, medical devices, and medical-surgical products and other such deliverables.Let's take the pharmacy market first!


There is already a scope for healthcare products/Devices and Pharma products as far as process management in the value chain are concerned.Introduction of M-commerce in health care value chain is also worth pondering over.



For eg. Mobiles can be useful in effectively managing a small scale industry supply chain.






















Similarly, managing prescription order workflow in a pharmacy network can be done using mobile phones. A workflow may define a sequence of queues. To complete the distributed processing of the prescription order, the task object may be passed along the queues, where each queue corresponds to a portion of work in processing a prescription order. The original order data object may be referenced in the task object or passed along with the task object.


Value = a MOBILITY service provider in a B2B value model, the value that it will pass on to the entire workflow would primarily be:


  1. Effective Communications
  2. Process Productivity

The revenue for a service provider would be fee-for-service business model. For most of the Value chain, Big Pharma Distributors like ABC say for example operate on a buy/hold business model under which a company would purchase drugs from manufacturers in large quantities based on what their own pricing models predicted would happen to the value of the drugs. Then ABC would sell the drugs to its customers for a higher price than that paid for the drugs. This set up is also evolving today and shifting focus, which can readily be addressed by Mobile Phones.


Wholesalers are shifting rapidly to a new, fee-for-service pricing strategy- in which suppliers pay directly for wholesaling services rather than having those services bundied and paid for indirectly through gross margin and unseen discounts.


Free for Service Model using Mobiles:




















ABC says “ABC has traditionally benefited from profits earned through buy-side opportunities from manufacturers .We have invested our profits in serving customers by dramatically increasing service levels over time. However, the manufacturers' model is changing, shifting to just-in-time inventory models that reduce our buy-side opportunities.”

ABC= “To support our investments in quality, technology and the future, we are making changes in how we do business. And while our goal is to insulate customers from changing economics whenever possible, we must make sure all our customers pay in a fair way for the value they receive." "We are moving toward a model in which manufacturers compensate us for distribution services on a fee-for-service basis."

Solutions/Services on Mobiles will help:

NEW Profits and Services
1. creating and managing service fee programs per contract
2. calculating, and managing fees as they accrue
3. setting up payment packages
4. accurately calculating payments based on incoming sales data
5. publishing this data to distributor’s (ABC) Pricing module on
6. a transaction-by-transaction basis

Traditional Profit margins:

The price wholesalers charged for servicing manufacturers dwindled down to a small, set discount


In today’s increasingly complicated supply chain, Mobile based (Solutions+ communications) contracts are a powerful tool for maintaining wholesaler relationships. Mobile based transactions as well as services will soon be used as a part of VAS to acquire data, manage inventory, and gain greater visibility into who’s buying once products. Because, although most of the companies want this feedback and snail-trail , they do not have the infrastructure to manage payments for these vital relationships.



Will come up with more…

Copyright @ Ruchi Bhatt ,Canadian Guild 2008

Popular posts from this blog

Artificial Intelligence Policy and Governance in HEALTHCARE

  Artificial Intelligence has become the new frontier for digital transformation. Several  #digitalhealth  businesses of today rely on Machine Learning,  #AI  and other such technologies to make healthcare delivery more efficient and comprehensive. However, the efficient and responsible use of AI tools is an ongoing discussion and would mean culture, data management, technology shifts in the industry, and required up-grading and training professionals for better coordination. Hence, with the growing market potential and interest in AI, it is imperative to develop a thoughtthrough regulatory and legal framework on the adoption and use of AI. I have set forward a hypotheses to design a policy framework for AI technologies in my paper- "𝐀𝐫𝐭𝐢𝐟𝐢𝐜𝐢𝐚𝐥 𝐈𝐧𝐭𝐞𝐥𝐥𝐢𝐠𝐞𝐧𝐜𝐞 𝐢𝐧 𝐇𝐞𝐚𝐥𝐭𝐡 𝐏𝐨𝐥𝐢𝐜𝐲 – 𝐀 𝐆𝐥𝐨𝐛𝐚𝐥 𝐏𝐞𝐫𝐬𝐩𝐞𝐜𝐭𝐢𝐯𝐞" last year https://lnkd.in/emi3XWwa cited further by "𝐓𝐡𝐞 𝐐𝐮𝐚𝐧𝐝𝐚𝐫𝐲 𝐢𝐧 𝐃𝐚𝐭𝐚 𝐏𝐫𝐨𝐭𝐞𝐜𝐭𝐢𝐨𝐧 𝐚𝐧𝐝 𝐑

Artificial intelligence and Technology for Dentistry

Have you heard of this company  ORCA Dental AI ? ORCA combines clinical expertise with machine learning and AI technologies to create diagnostic reports, treatment plan suggestions and smart clinical predictions. Good to learn about these innovations that benefit every stakeholder in the value chain. Recently,  VideaHealth  raised $20M to Expand AI-Based Diagnostics led by Spark Capital including existing investors Zetta Venture Partners. Among its many benefits to dentists and patients are: – A 31% increase in diagnosis rate for cavities and 26% increase in treatment plan value; – An increase in case acceptance by patients due to second opinions; – Automated workflows accelerate treatment planning and charting; Another company touting AI-powered dental care and practice management is  Overjet , which announced a $42.5 million Series B funding round in December months after it had scored $27 million in Series A funding.  Pearl  provides AI for dental images to assist in diagnosis. It l

Big Data Analytics- The Microscope and Telescope for Pharma/CRO

This article is produced in consultation with Industry experts, and KOLs in India and across the world and especially highlights how “Predictive Analytics algorithms” are poised to provide Useful Analytics to the Pharma industry.   In today’s highly competitive market, it is extremely important for contract research and manufacturers to have access to information that allows them to target the specific segments of the pharmaceutical and biotechnology industry that are looking to outsource the particular services they provide.  Understanding shifts in annual outsourcing budgets and spending can help CROs and CMOs to better position themselves for capturing business, particularly at a time when many – if not all – pharma and biotech companies are looking to cut costs and streamline operations.  As per a recent report by NiceInsights, Analytical Services, Clinical Research, and Clinical Monitoring will be the most demanded services over the next 12 to 18 months. For CROs and CMOs looki